1-4 of 4
Ma José Terol
Close
Sort by
Journal Articles

Thalidomide / Dexamethasone (TD) Vs. Bortezomib (Velcade) â /Thalidomide / Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcade â as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.

Laura Rosiñol, Ma Teresa Cibeira, Joaquin Martinez, Maria Victoria Mateos, Albert Oriol, Ma José Terol, Jose García-Laraña, Dolores Hernández, Javier de la Rubia, Anna Sureda, Juan Besalduch, Luis Palomera, Yolanda Gonzalez, Ma Asuncion Echebeste, Joaquin Díaz-Mediavilla, Felipe de Arriba, Adrian Alegre, Miguel T Hernández, Juan José Lahuerta, J.F F San Miguel, Joan Blade
Journal: Blood
Blood (2009) 114 (22): 130.
https://doi.org/10.1182/blood.V114.22.130.130
Published: 2009
Journal Articles

Bortezomib (Velcade)-Melphalan-Prednisone (VMP) Versus Velcade- Thalidomide-Prednisone (VTP) in Elderly Untreated Multiple Myeloma Patients: Which Is the Best Partner for Velcade: An Alkylating or An Immunomodulator Agent?

Maria-Victoria Mateos, Albert Oriol, Joaquín Martínez, Ma Teresa Cibeira, Raquel de Paz, Ma José Terol, José García-Laraña, Enrique Bengoechea, Rafael Martínez, Alejandro Martin, Felipe de Arriba, Luis Palomera, José Hernández, Jose-Luis Bello, María-Luisa Martín, Yolanda González, Joan Blade, MD, Juan José Lahuerta, J.F San Miguel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 651.
https://doi.org/10.1182/blood.V112.11.651.651
Published: 2008
Journal Articles

Thalidomide/Dexamethasone (TD) Vs. Bortezomib(Velcade®)/Thalidomide/Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcade® As Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Younger Patients with Multiple Myeloma (MM): First Results of a Prospective Phase III PETHEMA/Gem Trial

Laura Rosinol, M. Teresa Cibeira, Joaquin Martinez, Maria Victoria Mateos, Ma José Terol, Javier de la Rubia, Luis Palomera, Felipe de Arriba, Albert Oriol, Adrian Alegre, Juan Besalduch, Raquel de Paz, José Garcia-Laraña, Joaquín Díaz-Mediavilla, Anna Sureda, Juan José Lahuerta, J.F. San Miguel, Joan Blade
Journal: Blood
Blood (2008) 112 (11): 654.
https://doi.org/10.1182/blood.V112.11.654.654
Published: 2008
Journal Articles

Prognostic Value of Immunophenotyping of Multiple Myeloma: A Study on 685 Patients Uniformly Treated with High-Dose Therapy.

Gema Mateo, PhD, Maria A. Montalban, MD, Maria-Belén Vidriales, MD, Juan J. Lahuerta, MD, Maria-Victoria Mateos, MD, Norma C. Gutiérrez, MD, Laura Rosiñol, MD, Laura Montejano, MD, Ma Consuelo López-Berges, MD, Joan Bladé, MD, Rafael Martínez, MD, Javier de la Rubia, MD, Joaquín Diaz-Mediavilla, MD, Anna Sureda, MD, José M. Ribera, MD, José M. Ojanguren, MD, Felipe de Arriba, MD, Luis Palomera, MD, Ma José Terol, MD, Santiago Gardella, MD, Alberto Orfao, MD, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 1472.
https://doi.org/10.1182/blood.V110.11.1472.1472
Published: 2007